Companies: 10,795·Total market cap: $144.5T
Boston Scientific Corporation

Boston Scientific Corporation

BSXNYSEHealthcare● Active
$48.55
$-0.30(-0.61%)
Market Cap$72.2B
P/E Ratio—
52W High$109.5
52W Low$47.17
SEC Filings

Boston Scientific Corporation (BSX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000885725 · BSX · NYSE · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
4
Latest Form
2026-06-01
Most Recent
1992
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000885725 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-17
Fiscal Year End
Feb 17, 2026
Accession No.
0000885725-26-000010
Primary Document
bsx-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000885725 · Accession 0000885725-26-000010

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-01
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-18Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SDSD
SD
2026-05-21
View
8-KCurrent Report
8-K
2026-05-18
View
8-KCurrent Report
8-K
2026-05-18
View
S-8Employee Stock Plan Registration
FORM S-8
2026-05-08
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-06
View
8-KCurrent Report
8-K
2026-05-05
View
10-QQuarterly Report
10-Q
2026-05-01
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
425425
425
2026-04-22
View
8-KCurrent Report
8-K
2026-04-22
View
EFFECTEFFECT
EFFECT
2026-04-01
View
424B3424B3
424B3
2026-04-01
View
CORRESPCORRESP
CORRESP
2026-03-30
View
S-4/AS-4/A
S-4/A
2026-03-30
View
8-KCurrent Report
8-K
2026-03-30
View
Showing 1–15 of 216 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000885725  |  Exchange: NYSE · Healthcare

Boston Scientific Corporation (NYSE: BSX) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1992. As a Healthcare sector company with CIK 0000885725, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Boston Scientific Corporation's most comprehensive regulatory disclosure. The most recent Boston Scientific Corporation 10-K was filed on 2026-02-17 for fiscal year ending 2026. Historical BSX 10-K annual reports are available from 2020 through 2026.

Investors researching Boston Scientific Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
AMGN SEC Filings →GILD SEC Filings →ABT SEC Filings →PFE SEC Filings →DHR SEC Filings →SYK SEC Filings →SNY SEC Filings →MDT SEC Filings →
→ BSX Financials→ BSX Earnings→ BSX Insider Trades

Frequently Asked Questions

BSX SEC Filings · 8 questions

Boston Scientific Corporation (BSX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Boston Scientific Corporation's CIK is 0000885725.

BSX SEC filingsBoston Scientific Corporation SEC documentsfind BSX 10-K